Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.272,01
-0,28%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Exelixis Inc (EXEL) Exelixis Inc (EXEL) Notizie

Exelixis Inc

EXEL
33,48
-0,19 (-0,56%)
08 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202522:05BWExelixis to Release Fourth Quarter and Full Year 2024..
25/1/202516:00BWExelixis Announces Encouraging Results from Phase 1b/2..
24/1/202520:30BWExelixis Announces Results from Subgroup Analysis of Phase 3..
18/1/202503:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202503:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202503:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202503:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202503:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202522:34EDGAR2Form 8-K - Current report
12/1/202522:00BWExelixis Announces Preliminary Fiscal Year 2024 Financial..
09/1/202515:00BWExelixis Provides Update on Oncologic Drugs Advisory..
06/1/202522:05BWExelixis to Present at the 43rd Annual J.P. Morgan..
24/12/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202419:12EDGAR2Form 144 - Report of proposed sale of securities
27/11/202422:05BWExelixis to Webcast Fireside Chats as Part of Investor..
27/11/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:05BWExelixis Provides Regulatory Update Related to Supplemental..
22/11/202422:01EDGAR2Form 144 - Report of proposed sale of securities
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202400:50EDGAR2Form 144 - Report of proposed sale of securities
18/11/202422:10EDGAR2Form 144 - Report of proposed sale of securities
08/11/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:05BWExelixis to Webcast Fireside Chats as Part of Investor..
06/11/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
01/11/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202421:54EDGAR2Form 144 - Report of proposed sale of securities
01/11/202421:47EDGAR2Form 144 - Report of proposed sale of securities
30/10/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:10EDGAR2Form 144 - Report of proposed sale of securities
29/10/202421:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:07EDGAR2Form 8-K - Current report
29/10/202421:05BWExelixis Announces Third Quarter 2024 Financial Results and..
15/10/202422:15EDGAR2Form 8-K - Current report
15/10/202422:05BWExelixis to Release Third Quarter 2024 Financial Results on..
15/10/202419:57BWExelixis Announces Update on Second Patent Litigation Trial..
15/10/202414:00EDGAR2Form 8-K - Current report
14/10/202414:00BWExelixis and Merck Sign Clinical Development Collaboration..
09/10/202414:30PRNCAONCOLOGY COMMERCIALIZATION LEADER P.J. HALEY TO JOIN..
04/10/202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 33,60 Min: 33,1034 Max: 33,80
Chiusura: 33,67

La tua Cronologia

NASDAQ
EXEL
Exelixis
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci